Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ulrich Kunter"'
Publikováno v:
Arzneimittelforschung. 54:634-639
Sultamicillin (CAS 76497-13-7) is a pro-drug of a combination of ampicillin and sulbactam linked as a double ester. The aim of the present studies, performed in two different groups of volunteers, was to compare the bioavailability of 750 mg sultamic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757490370af731a75b80c0fcf8969b55
https://doi.org/10.1055/s-0031-1297062
https://doi.org/10.1055/s-0031-1297062
Autor:
Ulkem Erkent, Wolfram Richter, Velislava Dimitrova, Ulrich Kunter, Andreas Nern, Valentin Kirkov, Rossen Koytchev
Publikováno v:
Arzneimittelforschung. 59:557-563
A monocentric, open, randomised, single-dose, six-period crossover trial was carried out in healthy volunteers under fasting conditions to establish the most appropriate study design for a pivotal bioequivalence trial with acarbose (CAS 56180-94-0) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d78b03aad0f5fbb74b1c746cf273637
https://doi.org/10.1055/s-0031-1296444
https://doi.org/10.1055/s-0031-1296444
Publikováno v:
European journal of clinical pharmacology. 47(1)
The bioavailability of four preparations containing dihydrotachysterol (DHT2) was tested in two separate trials with administration of single, oral doses of 1 mg per individual. The relative bioavailability of corresponding preparations (capsules vs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad43cb5903eb3bd79f5fac4e18a3a36
https://pubmed.ncbi.nlm.nih.gov/7988630
https://pubmed.ncbi.nlm.nih.gov/7988630